Form D · Other

Switch Therapeutics Inc.

South San Francisco, CA · CIK 0001947761

Offering snapshot reported Nov 17, 2022 · SEC filing

Reported sold
$23.3M
Offering amount: $36M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 27, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.6M$23.3MOct 5, 2022: $19,870,995.00Oct 5, 2022Nov 17, 2022: $23,270,993.00Nov 17, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$19,870,995 → $23,270,993
  • Reported investors13 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2022Amendment$23,270,993$3,399,998vs Oct 5, 202215SEC filing
Oct 5, 2022Initial$19,870,995No comparison13SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-460733

Source: Form D, filed Nov 17, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Deepshikha Datta Director, Executive
Si Ping Han Executive
Alicia Irurzun Lafitte Director
Dylan Morris Director
Kevin Zhang Director

Issuer details

Industry: Other (See others in industry)

Address:
241 E Harris Ave
South San Francisco, CA, 94080